diseases most commonly responsive include lymphoma ( 74 % of the tested drugs rated active ) , leukemia ( 35 % ) , urothelial cancer ( 29 % ) , small cell lung cancer ( 29 % ) , ovarian cancer ( 22 % ) , cervical cancer ( 22 % ) , and breast cancer ( 18 % ) .
C0024299
lymphoma
C0006826
cancer